Clinical Trial Update: Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma

View source ↗

Summary

This clinical trial assesses perioperative risks associated with immunotherapy-based neoadjuvant and conversion therapy for hepatocellular carcinoma and is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Immunotherapy (immunotherapy)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Carcinoma, Hepatocellular, Immunotherapy | Status: RECRUITING